# T Cell Receptor Based Therapy of Metastatic Colorectal Cancer

> **NCT03431311** · PHASE1,PHASE2 · TERMINATED · sponsor: **Oslo University Hospital** · enrollment: 1 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** Adoptive Cell Therapy (ACT)

## Key facts

- **NCT ID:** NCT03431311
- **Lead sponsor:** Oslo University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-03-08
- **Primary completion:** 2019-06-12
- **Final completion:** 2019-06-12
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2019-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03431311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03431311, "T Cell Receptor Based Therapy of Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03431311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*